In the summer of 2024, as monsoon floods swept through Sindh province, health workers in the worst-hit districts faced a stark contrast: vials of oral cholera vaccine were expiring in temperature-controlled depots in Karachi, while in villages a few hundred kilometres away, families were dipping cups into open wells that floodwater had contaminated with Vibrio cholerae. The vaccine, a proven tool that can cut the risk of cholera by half or more, never made the journey from warehouse to village. The gap between a dose in storage and a dose in a child's mouth is not a technical problem. It is a policy choice, repeated every monsoon, with predictable and deadly consequences.

A Vaccine That Expires While the Outbreak Spreads

Cholera vaccines have a shelf life measured in months, not years. The oral vaccine used in most public campaigns, such as Shanchol or Euvichol, must be kept between 2 and 8 degrees Celsius from the moment it leaves the manufacturer until it is swallowed. That cold chain is fragile in the best of times. In Pakistan, where electricity outages in rural health facilities are routine and refrigeration units in district stores are often old or poorly maintained, the chain breaks long before the vaccine reaches the village.

The Karachi depots are the last stop before distribution. They are run by the provincial health department and stocked according to procurement forecasts made months earlier, often before the monsoon forecast is final. When flood waters rise faster than predicted, the planned distribution routes become impassable. Bridges wash out, roads turn to mud, and the vehicles that carry vaccines, which are not all-terrain, sit idle. Meanwhile, the clock ticks on every batch. A 2023 report from the provincial health department noted that over 2 million doses of oral cholera vaccine had expired in storage over the past five years, a figure that underscores the scale of the problem.

Public health experts have long pointed out that the global stockpile of oral cholera vaccine is finite and time-limited. The International Coordinating Group, which manages the emergency stockpile, releases doses based on requests from countries, but the total supply is far below what would be needed to vaccinate every at-risk person in a large outbreak. In Pakistan, as in other flood-prone countries, the decision to use the vaccine is made at the national level, but the actual delivery depends on provincial logistics that are chronically underfunded.

In practice, this means that when a batch approaches its expiry date, it is often used in urban centres where cold storage is reliable and transport is short. Rural districts, which face the highest risk of waterborne disease, are the last to receive doses, if they receive them at all. A 2023 review of cholera vaccination campaigns in South Asia found that the median time from vaccine arrival in the country to administration was over two months, and that delays were longest in flood-affected districts. By the time the vaccine reached some villages, the outbreak had already peaked.

The pattern is not inevitable. In Bangladesh, for instance, the government has pre-positioned vaccines in flood-prone districts before the monsoon, cutting delivery times dramatically. But in Pakistan, the logistics remain centralized, and the result is a recurring waste of a life-saving resource.

Flood Water, Open Wells, and a Resurgent Endemic

Cholera is not a new disease in Pakistan. It is endemic, meaning cases occur every year, usually peaking after the summer monsoon. The bacteria Vibrio cholerae lives naturally in brackish rivers and coastal waters, and it thrives in stagnant warm water. When floods cover the land, they mix sewage with drinking water sources. Open wells, which are the primary water supply for many rural households, become contaminated within days. The result is a rapid spike in cases, often within two to three weeks of the flood peak.

The 2022 floods, which submerged a third of the country, produced the largest cholera outbreak in decades. A similar pattern is unfolding in 2024. In the flood-hit villages of Sindh, families have no choice but to drink from the same surface water that carries the bacteria. Boiling water requires fuel, which is scarce and expensive. Chlorine tablets, if distributed at all, are often used incorrectly or run out quickly. The untreated water is the common denominator that turns a flood into a health emergency.

Karachi's urban slums face a similar risk, though the transmission dynamics differ. In the city, cholera spreads through contaminated piped water and street food, and cases cluster in low-income neighbourhoods where sanitation is poor. The urban poor are not spared, but they are closer to treatment centres. The rural poor, by contrast, may be hours from the nearest clinic, and the journey may be impossible when roads are flooded. For them, the vaccine is the only preventive measure that can be delivered before the water turns deadly.

Seasonal spikes are predictable, but floods amplify transmission by overwhelming the already fragile water and sanitation infrastructure. A 2021 study in the journal Emerging Infectious Diseases estimated that the risk of cholera infection in flood-affected areas is three to five times higher than in non-flooded areas during the same season. The data are not precise, but the direction is clear: floods are a multiplier for an endemic disease that is entirely preventable with clean water and a timely vaccine.

Antibiotic Resistance Turns a Treatable Disease into a Threat

Cholera is usually a self-limiting illness. The primary treatment is oral rehydration salts, which replace the fluids and electrolytes lost through profuse watery diarrhoea. With prompt rehydration, the case fatality rate can be kept below one percent. Antibiotics are not needed for most patients; they are reserved for severe cases to shorten the duration of shedding and reduce transmission. But when antibiotics are used, they must be effective, and resistance is eroding that effectiveness.

Over the past two decades, Vibrio cholerae has developed resistance to several first-line antibiotics. Tetracyclines, which were the mainstay of treatment in the 1990s, are now ineffective in many regions. Fluoroquinolones, such as ciprofloxacin, have also lost ground. A 2020 analysis of isolates from South Asia found that resistance to ciprofloxacin exceeded 50 percent in some outbreak settings, and resistance to azithromycin, a common alternative, is emerging. The World Health Organization now recommends that countries base their antibiotic choices on local susceptibility testing, but such testing is rarely available in the rural areas where cholera strikes hardest.

In Karachi, private laboratories can culture stool samples and report susceptibility patterns within a few days. In a flood village, there is no laboratory. The health worker at the basic health unit has a small stock of antibiotics and no way to know whether they will work. The result is that severe cases may be treated with drugs that do not clear the infection, prolonging illness and increasing the risk of complications. Some patients die of dehydration because the antibiotic they received gave them false confidence that they were being treated.

Resistance patterns shift by region and outbreak. What works in one district may fail in another, even within the same season. This variability makes it impossible to issue a single national treatment guideline that is always correct. The only robust response is to prevent infection in the first place, which brings the focus back to water, sanitation, and vaccination. But the same logistics that delay vaccines also delay the laboratory supplies and trained personnel needed for susceptibility surveillance.

The Wealth Gradient: Who Gets the Vaccine and Who Gets the Bottle

In Karachi, a private clinic in the upscale neighbourhood of Clifton can offer a rapid diagnostic test for cholera and prescribe oral rehydration salts or antibiotics within an hour. The patient pays for the test and the drugs, and the clinic's cool chain is never in doubt. Wealthy residents also have access to bottled water, filtration systems, and reliable electricity for refrigeration. Their risk of cholera is low, and when they do fall ill, they receive prompt, effective care.

In a rural village in the flood zone, the situation is reversed. There is no clinic, no diagnostic test, and no clean water. The only source of care may be a mobile health camp set up by a charity, which arrives days or weeks after the flood. The camp may have oral rehydration salts, but it rarely has vaccines. The distribution of vaccines in Pakistan has historically favoured urban centres, where cold storage and transport are easier, and where the disease burden is lower. This is a classic inverse care law: those who need the vaccine the most are the least likely to receive it.

The depot stockpiles reflect procurement decisions, not demand. The government buys vaccines based on national risk assessments, but the allocation to districts is often driven by logistical convenience rather than epidemiological need. A district with a good road and a functioning cold room gets the vaccine; a district with a dirt track and no electricity does not. The result is that the very places where cholera is most likely to spread are the places where the vaccine never arrives.

This wealth gradient is not unique to cholera. A similar pattern plays out in the distribution of dermoscopes for melanoma screening in rural Australia and in the allocation of mental health counselors in underfunded school districts. The common thread is that public health programmes, when resources are scarce, tend to follow the path of least resistance, which is almost always the path that leads to the already privileged.

Public Programme Design: Why Doses Languish in Warehouses

The reasons vaccines expire in depots are not mysterious. The cold chain in Sindh is fragile, with frequent power outages and a shortage of trained technicians to maintain refrigeration units. Distribution plans are made at the start of the season, but they lag behind the actual movement of flood water. When a road is washed out, there is no alternative route, and the vaccine sits in the depot until the road is repaired, which can take weeks.

Funding cycles also misalign with expiry dates. The federal government allocates funds for vaccine procurement at the beginning of the fiscal year, but the monsoon arrives later, and the funds may be spent on other priorities by then. Provincial health departments often have to request emergency releases from the federal government, which adds bureaucratic delays. By the time the funds are approved and the vaccine is purchased, the outbreak is already underway, and the vaccine may be close to expiry.

Immunization campaigns require more than just the vaccine. They require cold storage, trained staff, and a plan for reaching remote populations. In flood conditions, these requirements become even more demanding. Health workers may need to travel by boat, which is not always available. The campaign may be postponed until conditions improve, but the vaccine does not wait.

Coordination between federal and provincial bodies is weak. The federal government is responsible for procurement and international coordination, while the provinces are responsible for distribution and administration. Communication between the two levels is often slow, and there is no real-time system for tracking vaccine stocks and expiry dates. A simple dashboard that shows which depot has which batch and when it expires would be a low-cost improvement, but it has not been implemented.

What Works: Evidence from Past Outbreaks and Pilot Programs

Despite these failures, there is evidence that cholera vaccination can work in challenging settings. In Zambia, during the 2016 outbreak, a mass vaccination campaign targeted high-risk districts and achieved coverage of over 80 percent. The campaign was associated with a 50 to 60 percent reduction in cholera cases in vaccinated areas. The key was that the vaccine was pre-positioned in the districts before the outbreak peaked, and the campaign was run by local health workers who knew the terrain.

Rapid response teams, which combine vaccination with water treatment and hygiene education, have also shown promise. In the Democratic Republic of the Congo, a 2017 pilot programme used mobile teams to deliver vaccines and chlorine tablets to remote villages along the Congo River. The programme reduced the case fatality rate to below one percent, even in areas where the vaccine coverage was incomplete. The lesson is that vaccines are most effective when they are part of a comprehensive package that includes clean water and sanitation.

Surveillance systems can also help. In Bangladesh, a long-standing cholera surveillance programme in Dhaka has enabled early detection of outbreaks and rapid deployment of vaccines. A similar system in Pakistan could alert health authorities to the first cases in a flood-affected district, allowing them to target vaccination before the outbreak spreads. The cost of such a system is modest compared to the cost of treating a large outbreak.

However, these successes are not guaranteed to translate to other settings. Zambia and Bangladesh have different logistics and political contexts. The evidence supports the idea that vaccination is a useful tool, but it is not a silver bullet. The real solution to cholera is clean water and sanitation, which require sustained investment and political will. Vaccines are a stopgap, not a cure.

Moreover, the proposed fixes come with trade-offs. Pre-positioning vaccines, for instance, requires moving them into flood-prone areas before they are needed, which could expose them to the very floods they are meant to mitigate. If the monsoon is mild, the vaccines may expire in district cold rooms instead of Karachi depots, shifting the problem rather than solving it. Expiry-date tracking systems require reliable internet and electricity, which are often lacking in rural health facilities. Training local health workers is essential, but high staff turnover means that the investment may be lost within a year or two. And integrating vaccination with water and sanitation programmes, while sensible, requires overcoming bureaucratic silos that have persisted for decades.

There is also the risk of unintended consequences. If vaccines are pre-positioned and not used, they may create a false sense of security, leading communities to neglect water treatment and hygiene. The cost of these measures, though modest compared to outbreak response, can divert resources from other pressing health needs, such as maternal care or childhood immunization. Finally, the global stockpile is limited, and using it more flexibly could deplete it for other countries facing simultaneous outbreaks. These are not reasons to abandon the fixes, but they are reasons to implement them carefully, with clear criteria for activation and deactivation.

Practical Fixes: From Depot to Village Before the Next Monsoon

There are practical steps that could reduce the number of vaccines that expire in depots. First, pre-position vaccines in flood-prone districts before the monsoon season begins. This means moving the vaccine from Karachi to district cold rooms in May or June, when the roads are still passable. The vaccine would be stored closer to the villages, and the distribution time would be cut from weeks to days. However, this requires careful planning to avoid waste in mild seasons, and it may be more cost-effective to pre-position only a portion of the stock, with the rest kept in reserve.

Second, implement an expiry-date tracking system with automated alerts. A simple digital tool that sends a notification when a batch is within three months of expiry could prompt health authorities to use it before it is too late. Such a system would require investment in data management, but it is not technically difficult. The same system could be used to monitor cold chain temperatures and flag breakdowns. To overcome connectivity issues, the system could be designed to work offline and sync when a connection is available.

Third, train local health workers in cold chain management. In many districts, the health worker who is responsible for the vaccine refrigerator has no formal training in maintaining it. A one-day course on temperature monitoring and basic maintenance could prevent many vaccine losses. The training should be repeated annually, as staff turnover is high. To make the training sustainable, a train-the-trainer model could be used, where a small team of master trainers is certified and then trains others.

Fourth, integrate vaccination with water, sanitation, and hygiene programmes. A vaccination campaign that also distributes chlorine tablets and water filters can have a greater impact than one that only vaccinates. This requires coordination between the health and water departments, which is often lacking. A joint plan, agreed before the monsoon, would help. For example, in a pilot in Sindh in 2023, a campaign that combined oral cholera vaccine with household water filters and hygiene kits reached 80 percent of households in a flood-affected union council, and a follow-up survey found a 40 percent reduction in diarrheal disease.

Finally, fund flexible procurement tied to seasonal forecasts. Instead of buying a fixed quantity of vaccine at the start of the year, the government could purchase an option to buy more vaccine if the monsoon forecast predicts heavy rains. This would require a different procurement model, but it would allow the supply to match the demand. The global stockpile could also be used more flexibly, with doses released earlier in the season based on forecast risk. However, this would require changes to the international allocation process, which is not easy.

These fixes are not radical, but they require political will and sustained funding. They also require a recognition that the problem is not just logistical but structural. The next monsoon is already on the horizon, and the same cycle of expiry and infection is likely to repeat unless something changes. The challenge is not to find a perfect solution, but to implement imperfect solutions that move the needle, while continuing to invest in the long-term goal of universal access to clean water.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. The information presented here is not intended to replace clinical judgment, and any treatment decisions should be made in consultation with a qualified healthcare professional.